as on December 24, 2025 at 4:01 pm IST
Day's Low
Day's High
0.21%
Downside
4.77%
Upside
52 Week's Low
52 Week's High
66.29%
Downside
4.77%
Upside
as on December 24, 2025 at 4:01 pm IST
Market Cap
₹1,090.68 Cr
Return on Equity (ROE)
8.1
PE Ratio (TTM)
15.51
Return on capital employed (ROCE)
11.75
Industry PE ratio
42.26
Beta (LTM)
1.05
P/B Ratio
0.68
Dividend Yield
0PEG Ratio
0.43
Quarterly Earnings Growth YOY
473.5
EPS (TTM)
33.9
Sector
Pharmaceuticals
Book Value
419.65
Technical Analysis
Bullish
View Technical Analysis
as on December 24, 2025 at 4:01 pm IST
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (15.51x)
December 23, 2025
Industry (42.26x)
December 23, 2025
Highest (21.70x)
December 28, 2023
Today’s Price to Earnings Ratio: 15.51x
Compare market cap, revenue, PE, and other key metrics of Venus Remedies with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,090.68 | 102.47% | 0.50 | 45 | 647 | |
| NA | 242.47 | 82.73% | 0.00 | 9 | 66 | |
| BUY | 14,059.37 | 8.51% | 0.50 | 371 | 1,200 | |
| NA | 117.54 | 6.73% | 0.84 | 7 | 303 | |
| NA | 0.00 | 5.11% | -5.26 | NA | NA |
Get share price movements and forecasts by analysts on Venus Remedies.
Source: S&P Global Market Intelligence
Search interest for Venus Remedies Ltd Stock has increased by 82% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:82% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Venus Remedies.
Venus Remedies Ltd’s net profit jumped 473.5% since last year same period to ₹20.13Cr in the Q2 2025-2026. On a quarterly growth basis, Venus Remedies Ltd has generated 109.69% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2013, Venus Remedies Ltd has declared dividend of ₹3.00 per share on 20 May 2013 - translating a dividend yield of 0.75%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 1 Year
![]()
In the last 1 year, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 140.59 Cr → 194.46 Cr (in ₹), with an average increase of 27.7% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 9.6 Cr → 20.13 Cr (in ₹), with an average increase of 52.3% per quarter
Price Rise
![]()
In the last 1 month, VENUSREM stock has moved up by 13.8%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 41.76% of holdings in Sep 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 55.89% to 55.63% in Sep 2025 quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 2.24% to 1.86% in Sep 2025 quarter
| Organisation | Venus Remedies Ltd |
| Headquarters | Panchkula |
| Industry | Pharmaceuticals |
| CEO | Pawan Chaudhary |
| E-voting on shares | Click here to vote |
Venus Remedies share price today stands at ₹801.65 as on at the close of the market. Venus Remedies share today touched a day high of ₹839.9 and a low of ₹800.
Venus Remedies touched a 52 week high of ₹839.9 and a 52 week low of ₹270.25. Venus Remedies share price today i.e. is closed at ₹801.65, which is -4.55% down from its 52 week high and 196.63% up from its 52 week low.
Venus Remedies market capitalisation is ₹1,090.68 Cr as on .
To buy Venus Remedies shares, you need to follow these steps:
Venus Remedies trading volume is 35.04K as on . This means that 35.04K shares of Venus Remedies were bought and sold on the stock market during today's trading session.